[Genomic classification and survival of patients with rhabdomyosarcoma: a report from an international consortium]
- PMID: 35230459
- DOI: 10.1007/s00066-022-01908-3
[Genomic classification and survival of patients with rhabdomyosarcoma: a report from an international consortium]
Comment on
-
Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium.J Clin Oncol. 2021 Sep 10;39(26):2859-2871. doi: 10.1200/JCO.20.03060. Epub 2021 Jun 24. J Clin Oncol. 2021. PMID: 34166060 Free PMC article.
References
Literatur
-
- Skapek SX et al (2019) Rhabdomyosarcoma. Nat Rev Dis Primers 5(1):1 - DOI
-
- Malempati S, Hawkins DS (2012) Rhabdomyosarcoma: review of the children’s oncology group (COG) soft-tissue sarcoma committee experience and rationale for current COG studies. Pediatr Blood Cancer 59(1):5–10 - DOI
-
- Oberlin O et al (2008) Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups. J Clin Oncol 26(14):2384–2389 - DOI
-
- Klingebiel T et al (2008) Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial. Pediatr Blood Cancer 50(4):739–745 - DOI
-
- Meza JL et al (2006) Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children’s Oncology Group. J Clin Oncol 24(24):3844–3851 - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
